首页> 外文期刊>PLoS One >Localized Fetomaternal Hyperglycemia: Spatial and Kinetic Definition by Positron Emission Tomography
【24h】

Localized Fetomaternal Hyperglycemia: Spatial and Kinetic Definition by Positron Emission Tomography

机译:局限性Fetomaternal高血糖:正电子发射断层扫描的空间和动力学定义。

获取原文
           

摘要

Background Complex but common maternal diseases such as diabetes and obesity contribute to adverse fetal outcomes. Understanding of the mechanisms involved is hampered by difficulty in isolating individual elements of complex maternal states in vivo. We approached this problem in the context of maternal diabetes and sought an approach to expose the developing fetus in vivo to isolated hyperglycemia in the pregnant rat. Methodology and Principal Findings We hypothesized that glucose infused into the arterial supply of one uterine horn would more highly expose fetuses in the ipsilateral versus contralateral uterine horn. To test this, the glucose tracer [18F]fluorodeoxyglucose (FDG) was infused via the left uterine artery. Regional glucose uptake into maternal tissues and fetuses was quantified using positron emission tomography (PET). Upon infusion, FDG accumulation began in the left-sided placentae, subsequently spreading to the fetuses. Over two hours after completion of the infusion, FDG accumulation was significantly greater in left compared to right uterine horn fetuses, favoring the left by 1.9±0.1 and 2.8±0.3 fold under fasted and hyperinsulinemic conditions (p10−11 n = 32-35 and p10−12 n = 27–45) respectively. By contrast, centrally administered [3H]-2-deoxyglucose accumulated equally between the fetuses of the two uterine horns. Induction of significant hyperglycemia (103 mg/dL) localized to the left uterine artery was sustained for at least 48 hours while maternal euglycemia was maintained. Conclusions and Significance This approach exposes selected fetuses to localized hyperglycemia in vivo, minimizing exposure of the mother and thus secondary effects. Additionally, a set of less exposed internal control fetuses are maintained for comparison, allowing direct study of the in vivo fetal effects of isolated hyperglycemia. Broadly, this approach can be extended to study a variety of maternal-sided perturbations suspected to directly affect fetal health.
机译:背景技术复杂但常见的孕产妇疾病(例如糖尿病和肥胖症)会导致不良的胎儿结局。由于难以在体内分离出复杂的母体状态的各个元素,因此妨碍了对所涉及机制的理解。我们在孕产妇糖尿病的背景下解决了这个问题,并寻求一种将发育中的胎儿体内暴露于妊娠大鼠中孤立的高血糖症的方法。方法学和主要发现我们假设将葡萄糖注入到一个子宫角的动脉供应中将使同侧和对侧子宫角中的胎儿更多地暴露。为了对此进行测试,通过左子宫动脉注入了葡萄糖示踪剂[18F]氟脱氧葡萄糖(FDG)。使用正电子发射断层扫描(PET)定量分析母体组织和胎儿的局部葡萄糖摄取。输注后,FDG开始在左侧胎盘中积累,随后扩散到胎儿。输注完成后的两个小时内,左FDG的积聚明显多于右子宫角胎儿,在禁食和高胰岛素血症的情况下,左FDG积聚了1.9±0.1和2.8±0.3倍(p <10-11 n = 32- 35和p <10-12 n = 27-45)。相比之下,集中给药的[3H] -2-脱氧葡萄糖在两个子宫角的胎儿之间平均积累。维持母体正常血糖的同时,持续诱导至少定位于子宫左动脉的高血糖(103 mg / dL)。结论和意义这种方法使选定的胎儿在体内暴露于局部高血糖状态,从而最大程度地减少了母亲的暴露,从而最大程度地降低了继发性影响。另外,保留一组较少暴露的内部对照胎儿用于比较,从而可以直接研究分离的高血糖的体内胎儿作用。从广义上讲,这种方法可以扩展到研究各种可能直接影响胎儿健康的产妇侧扰动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号